Meta-analysis of 4 mainly retrospective studies (110 patients) with cancer therapy-related cardiac dysfunction: after cardiac resynchronisation therapy, LVEF rose by 9.95% and end-systolic volume fell by 39.17 mL over a mean 9 months; evidence is limited.
Meta-analysisn = 110
Magalhães et al. Effectiveness of cardiac resynchronization therapy in cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis